Page last updated: 2024-09-04

irofulven and Acute Promyelocytic Leukemia

irofulven has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Estes, L; Kelner, MJ; MacDonald, JR; McMorris, TC; Samson, KM; Trani, NA1

Other Studies

1 other study(ies) available for irofulven and Acute Promyelocytic Leukemia

ArticleYear
Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with topotecan.
    Leukemia, 2000, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Agents; Drug Synergism; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred BALB C; Mice, Nude; Sesquiterpenes; Topotecan

2000